Comprehensive Dermatologic Drug Therapy, Fourth Edition
Dapsone
Publication
, Chapter
Bhatia, SM; Hall, RP
January 1, 2020
Dapsone is a sulfonamide derived antibiotic that is a mainstay of therapy for leprosy and Pneumocystis jirovecii infection. This chapter will however focus on its use in numerous inflammatory skin diseases. Dapsone is highly effective in the management of inflammatory dermatosis with a predominant neutrophilic infiltrate, such as dermatitis herpetiformis. Although dapsone has many pharmacologic and idiosyncratic adverse events, a complete understanding of the drug's pharmacology as well as proposed mechanisms of action, will allow the clinician to use maximize the therapeutic benefit of dapsone and minimize the likelihood of significant adverse events.
Duke Scholars
DOI
ISBN
9780323612128
Publication Date
January 1, 2020
Start / End Page
222 / 233.e4
Citation
APA
Chicago
ICMJE
MLA
NLM
Bhatia, S. M., & Hall, R. P. (2020). Dapsone. In Comprehensive Dermatologic Drug Therapy, Fourth Edition (pp. 222-233.e4). https://doi.org/10.1016/B978-0-323-61211-1.00020-6
Bhatia, S. M., and R. P. Hall. “Dapsone.” In Comprehensive Dermatologic Drug Therapy, Fourth Edition, 222-233.e4, 2020. https://doi.org/10.1016/B978-0-323-61211-1.00020-6.
Bhatia SM, Hall RP. Dapsone. In: Comprehensive Dermatologic Drug Therapy, Fourth Edition. 2020. p. 222-233.e4.
Bhatia, S. M., and R. P. Hall. “Dapsone.” Comprehensive Dermatologic Drug Therapy, Fourth Edition, 2020, pp. 222-233.e4. Scopus, doi:10.1016/B978-0-323-61211-1.00020-6.
Bhatia SM, Hall RP. Dapsone. Comprehensive Dermatologic Drug Therapy, Fourth Edition. 2020. p. 222-233.e4.
DOI
ISBN
9780323612128
Publication Date
January 1, 2020
Start / End Page
222 / 233.e4